Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report

Massimiliano Fambrini, Gianni Bargelli, Elena Peruzzi, Anna Maria Buccoliero, Annalisa Pieralli, Karin L Andersson, Karin Louise Andersson, Gianfranco Scarselli, Marcella Gallorini, Federica Zolfanelli, Mauro Marchionni
Journal of Minimally Invasive Gynecology · 2009 · vol. 16(5) , pp. 630–633 · doi:10.1016/j.jmig.2009.05.007 · PMID:19835809 · W2033782194
Case report OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This case report describes the successful primary treatment of early endometrial cancer in a young woman using a levonorgestrel-releasing intrauterine system.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Young women with polycystic ovary syndrome (PCOS) are at increased risk of endometrial adenocarcinoma (EAC) through chronic unopposed estrogen production. We describe the first case, to our knowledge, of grade 1 endometrioid EAC arising in the context of complex atypical endometrial hyperplasia in a 26-year-old woman with thrombophilia and PCOS who wished to retain fertility potential and was treated using a levonorgestrel-releasing intrauterine system alone. At first follow-up biopsy, a single focus of complex hyperplasia without atypia was documented. All specimens sampled during subsequent follow-up demonstrated inactive endometrium with pseudodecidual changes, and no ultrasonographic or magnetic resonance (MR) images exhibiting myometrial invasion or endoabdominal spread were observed. This successful outcome suggests that insertion of a levonorgestrel-releasing intrauterine system is a treatment option in selected young women with early-stage EAC who are not candidates for systemic therapy and who wish to maintain fertility potential. Close histologic follow-up is required, and immediate surgery is mandatory if endometrial cancer persists.

My notes (saved in your browser only)

MeSH descriptors

Adenocarcinoma Contraceptive Agents, Female Endometrial Neoplasms Intrauterine Devices Levonorgestrel Adenocarcinoma Adenocarcinoma Adult Comorbidity Contraceptive Agents, Female Endometrial Neoplasms Endometrial Neoplasms Female Humans Levonorgestrel Polycystic Ovary Syndrome Polycystic Ovary Syndrome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (30)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:06:57.459801+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK